Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Biorenova Societa' Per Azioni currently manages 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This activity involves a distinct examiner and a distinct art unit.
The busiest examiner for the company is EPSTEIN, TODD MATTHEW, who handles 1 pending office action. Prosecution is currently limited to this specific examiner and art unit, simplifying the strategic focus for the practitioner.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| EPSTEIN, TODD MATTHEW | 1 | 60.8% | +43.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17999757 | PROCESS FOR THE BIOLOGICAL PRODUCTION OF HYDROGEN AND/OR METHANE BY ABSORPTION AND BIOLOGICAL CONVERSION OF CARBON DIOXIDE | EPSTEIN, TODD MATTHEW | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17999757 | PROCESS FOR THE BIOLOGICAL PRODUCTION OF HYDROGEN AND/OR METHANE BY ABSORPTION AND BIOLOGICAL CONVERSION OF CARBON DIOXIDE | EPSTEIN, TODD MATTHEW | — |
| Art Unit | Apps |
|---|---|
| 1652 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17999757 | PROCESS FOR THE BIOLOGICAL PRODUCTION OF HYDROGEN AND/OR METHANE BY ABSORPTION AND BIOLOGICAL CONVERSION OF CARBON DIOXIDE | EPSTEIN, TODD MATTHEW | 1652 | §103§112 | Final Rejection | — | Pending | Nov 23, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialBiorenova Societa' Per Azioni has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Todd Matthew Epstein has the most, with 1 of Biorenova Societa' Per Azioni's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
